Comparison of efficacy of laser Q-Switch 1,064 nm Nd: YAG with two different methods in the treatment of Malasma
Phase 3
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT201308181159N9
- Lead Sponsor
- Vice Chancellor for Research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Age between 18 and 85 years old; Fitzpatrick skin type I-V; symmetric distribution of melasma the in both sides of patient's face;
Exclusion criteria: -usage of pigment reducing topical treatments 2 weeks prior to the study -usage of peeling agents 2 weeks prior to the study -laser therapy for melasma 1 month prior to the study, and solarium usage one month prior to the treatment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melanin Index. Timepoint: Before laser therapy. Method of measurement: Multi Probe adaptor.
- Secondary Outcome Measures
Name Time Method